An Indian palace, fireworks, Jennifer Lopez, and a who’s‑who guest list including Donald Trump, Jr. sell a fantasy of unlimited wealth at the Netra Mantena–Vamsi Gadiraju wedding. This isn’t about hating the rich; it’s about how the specific business models behind Superorder and Ingenus Pharmaceuticals step on everyone else to get there.
The driver is sold a dream: be an “independent contractor,” grind hard, and you can get rich. In reality, a driver pulling in about $30,000 from apps pays the full self‑employment tax on top of income tax and eats every cost—gas, repairs, insurance, unpaid waiting for tax reimbursement. By the time all that is stripped out, the take‑home often sinks toward minimum wage or worse, with no benefits and constant fear of getting crushed at tax time. The “be your own boss” pitch becomes a trap for the worker and a tax‑advantaged pipeline for the founder of Superorder, whose company skims revenue from those same orders inside a corporate structure loaded with write‑offs and legal shields.
On the bride’s side, her father’s company, Ingenus Pharmaceuticals, profits from psychiatric and other central nervous system drugs—chemicals acting directly on the brain and spinal cord. These generics move quietly through pharmacies and hospitals under forgettable labels, while families often never get full, honest informed consent about suicidality, aggression, dependence, or withdrawal. When lives are shattered, the system blames “underlying illness,” not the executives whose fortunes depend on keeping those drugs flowing.
Dangers of psychiatric drugs
